Roche escapes antitrust lawsuit from Russian drugmaker Biocad by Eric Sagonowsky Wednesday, November 6, 2019 Biocad accused Roche of playing dirty in Russia to thwart its biosimilar ambitions in the U.S., but an appeals court tossed the suit.
Takeda's emerging markets cull reaches Russia by Angus Liu Tuesday, November 5, 2019 In the largest acquisition in Stada's history, the German generics maker is laying out $660M for 20 Takeda drugs in the Commonwealth states.
GSK to make chickenpox vaccine in Russia in deal with Nanolek by Eric Palmer Wednesday, September 25, 2019 With vaccines continuing to produce double digit growth, GlaxoSmithKline has a deal that will allow for local production in Russia.
Merck targeted in global ransomware attack by Eric Sagonowsky Tuesday, June 27, 2017 A massive ransomware attack infiltrated computer systems around the world on Tuesday, affecting pharma giant Merck in the U.S.
Russia slashes spending on cancer drugs: Report by Arlene Weintraub Thursday, June 22, 2017 Russia is pushing back on an issue that has raised concerns around the world: cancer drug prices.
Plant to produce Pfizer injectables for Russia gets under way by Eric Palmer Wednesday, May 31, 2017 Russia-based NovaMedica has started work on a new plant where it will produce 30 Pfizer sterile injected generic meds for the local market.
Magnetic blood clot dissolver could be 4,000 times more efficient by Michael Gibney Tuesday, June 28, 2016 Researchers at ITMO University in St. Petersburg, Russia, have developed a magnetically controlled treatment designed to dissolve blood clots.
Boehringer Ingelheim and Cipla transferring manufacturing tech to Russian companies by Eric Palmer Tuesday, June 21, 2016 Russia has made it clear that it wants foreign manufacturers to produce drugs locally and transfer technology to the country in the process. Both Germany’s Boehringer Ingelheim and India’s Cipla have struck separate deals that will do that.
